Geode Capital Management’s Vigil Neuroscience VIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-304,071
Closed -$2.42M 4570
2025
Q2
$2.42M Buy
304,071
+59,537
+24% +$267K ﹤0.01% 3079
2025
Q1
$435K Buy
244,534
+16,010
+7% +$35.9K ﹤0.01% 3597
2024
Q4
$389K Buy
228,524
+2,441
+1% +$7.21K ﹤0.01% 3687
2024
Q3
$769K Buy
226,083
+66,712
+42% +$247K ﹤0.01% 3447
2024
Q2
$638K Sell
159,371
-174,871
-52% -$598K ﹤0.01% 3483
2024
Q1
$1.14M Buy
334,242
+18,704
+6% +$58.4K ﹤0.01% 3324
2023
Q4
$1.07M Buy
315,538
+10,363
+3% +$53.3K ﹤0.01% 3335
2023
Q3
$1.65M Buy
305,175
+20,332
+7% +$140K ﹤0.01% 3139
2023
Q2
$2.68M Buy
284,843
+172,451
+153% +$1.63M ﹤0.01% 3019
2023
Q1
$1.1M Buy
112,392
+8,625
+8% +$97K ﹤0.01% 3304
2022
Q4
$1.3M Buy
103,767
+31,948
+44% +$392K ﹤0.01% 3237
2022
Q3
$653K Buy
71,819
+12,174
+20% +$89.3K ﹤0.01% 3594
2022
Q2
$153K Sell
59,645
-37,435
-39% -$148K ﹤0.01% 4406
2022
Q1
$682K Buy
+97,080
New +$1.28M ﹤0.01% 3788

Other funds holding VIGL